Farms.com Home   News

Alberta Wheat Commission Reminding Farmers To Apply For The SR&ED Tax Credit

Producers who paid their Alberta Wheat Commission check-off are eligible for a 31 per cent tax credit for their investment in wheat research and development projects.
 
The tax credit is available through the Scientific Research & Experimental Development Fund program.
 
The federal program encourages R&D investment through tax-based incentives, giving claimants tax credits for their expenditures on eligible R&D work.
 
The tax credit percentage is based on the amount invested in R&D that meets the criteria laid out by the Canada Revenue Agency.
 
Farmers should use form T2038 (IND) to claim the credit, while farm corporations must use form T2SCH31 when filing their taxes.
 
Farmers who have requested a refund on their check-off are not eligible for the tax credit.
 
More information on the research and development tax credit (SR&ED program) is available from the Canada Revenue Agency.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.